EUVIMEDEUVIMED entdecken
Editorial

Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier

Karunya K Kandimalla iD

Molecular Pharmaceutics · 03.11.2025 · 22 (11) · 6395-6397

DOI: 10.1021/acs.molpharmaceut.5c01417 ↗

Kurz gefasst

Editorial in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.11.2025. Verfasst von Karunya K Kandimalla. Beteiligte Einrichtung: Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United St…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Institutes of Health/National Institute of Neurological Disorders and Stroke/National Institute for Aging.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.

ORCID-Profile: Karunya K Kandimalla

Förderung

  • National Institutes of Health/National Institute of Neurological Disorders and Stroke/National Institute for Aging

Zitieren

APA

Kandimalla, K. K. (2025). Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier. Molecular Pharmaceutics, 22(11), 6395-6397. https://doi.org/10.1021/acs.molpharmaceut.5c01417

Vancouver

Kandimalla KK. Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier. Molecular Pharmaceutics. 2025;22(11):6395-6397. doi:10.1021/acs.molpharmaceut.5c01417

BibTeX
@article{Kandimalla2025,
  author = {Kandimalla, Karunya K},
  title = {Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {11},
  pages = {6395--6397},
  doi = {10.1021/acs.molpharmaceut.5c01417}
}
Kostenlos starten →